Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-c Insulin Resistance Research Mechanism: Study Comparison

Lee et al., Cell Metabolism 2015. HFD-fed mice 5 mg/kg IP, 3×/week for 4 weeks Glucose tolerance (GTT AUC) 50% improvement in glucose clearance AMPK activation in muscle, increased GLUT4 translocation Landmark study. Established dose-response and tissue specif

This comparison does not assign a generated winner or score.

  • Lee et al., Cell Metabolism 2015. HFD-fed mice
  • 5 mg/kg IP, 3×/week for 4 weeks
  • Glucose tolerance (GTT AUC)
  • 50% improvement in glucose clearance
  • AMPK activation in muscle, increased GLUT4 translocation
  • Landmark study. Established dose-response and tissue specificity for metabolic rescue
  • Reynolds et al., Nature Medicine 2021. Insulin-resistant myotubes
  • 10–100 nM in vitro, 48-hour treatment
  • Glucose uptake rate (2-deoxyglucose assay)
  • 60–80% increase at 100 nM
  • PGC-1α upregulation, mitochondrial biogenesis
  • Confirms insulin-independent glucose uptake mechanism at cellular level
  • Kim et al., Diabetes 2018. Ob/ob leptin-deficient mice
  • 15 mg/kg SC, 2×/week for 6 weeks
  • Fasting glucose, HOMA-IR, adiponectin
  • 35% reduction in fasting glucose, 45% HOMA-IR improvement
  • Adiponectin increase, reduced hepatic gluconeogenesis
  • Demonstrates efficacy in severe genetic insulin resistance model
  • Ming et al., Aging Cell 2021. Aged mice (18 months)
  • 5 mg/kg IP, daily for 8 weeks
  • Mitochondrial respiration, insulin signaling
  • Restored mitochondrial oxygen consumption to young-mouse levels
  • AMPK-PGC-1α pathway activation
  • Age-related insulin resistance responds similarly to diet-induced models
More references

Related material